SNM celebrates Nuclear Medicine Week

The Society of Nuclear Medicine has announced the theme for this year’s Nuclear Medicine Week, Oct. 2-8, is “Visualizing a Brighter and Healthier Tomorrow,” and released a toolkit for nuclear and molecular imaging professionals.

The toolkit includes a fact sheet, sample letter to government officials, sample media materials and suggested activities for the week—including issuing a public service announcement, holding an open house of the nuclear and molecular imaging department for the public and hosting an appreciation luncheon for employees.

SNM said it is working to increase understanding of the value of nuclear medicine and molecular imaging, and Nuclear Medicine Week is a chance to recognize advances in the field, as well as the professionals who carry out these procedures.

More than 16 million Americans undergo nuclear medicine procedures each year for a variety of conditions, including cancer, cardiovascular disease, neurological conditions and other physiological problems, SNM said.
Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.